证券记录 · 已归档季度
ACAD
ACADIA Pharmaceuticals Inc. · Healthcare · Biotechnology
15被追踪持有人
+1Δ持有人
20.32M持有股份
$372.93M报告持仓市值
+1新建仓位
−0清仓
动量输入（同类管理人）：
持有人广度 +7.1% ·
股份流向 +12.0% ·
净新建仓位 +6.7%
— 公式
广泛积累 — 持股数量上升且持有人增多
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q4 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 122 | +9 | 90.95M | $2.30B | +11 | −1 |
| Q1 2026 | 115 | -3 | 85.30M | $1.90B | +4 | −8 |
| Q4 2025 | 119 | 0 | 93.96M | $2.51B | +1 | — |
| Q3 2025 | 23 | +1 | 66.53M | $1.42B | +1 | −1 |
| Q2 2025 | 20 | +2 | 61.51M | $1.33B | +2 | — |
| Q1 2025 | 15 | 0 | 22.54M | $374.41M | — | — |
| Q4 2024 | 15 | +1 | 20.32M | $372.93M | +1 | — |
| Q3 2024 | 13 | -1 | 13.63M | $209.57M | — | −1 |
| Q2 2024 | 14 | — | 19.35M | $314.37M | — | — |
持有人 · Q4 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (被动) | 4.52M | — | $82.97M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | D. E. Shaw & Co. ✦ | 3.24M | -7.5% | $59.48M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 3 | D. E. Shaw & Co. ✦ | 3.24M | -7.5% | $59.48M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 4 | Geode Capital Management ✦ (被动) | 2.88M | +0.1% | $52.81M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Geode Capital Management ✦ (被动) | 2.88M | +0.1% | $52.81M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | Point72 Asset Management ✦ | 2.23M | 新增 | $40.94M | 0.1% | New | 1 | SEC ↗ |
| 7 | Norges Bank ✦ (被动) | 1.39M | +4.5% | $25.55M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 8 | Two Sigma Investments ✦ | 1.24M | +12.0% | $22.82M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 9 | Renaissance Technologies ✦ | 1.23M | +204.2% | $22.51M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 10 | Millennium Management ✦ | 1.12M | -45.5% | $20.52M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 11 | Marshall Wace ✦ | 993.59K | -16.4% | $18.23M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 12 | Marshall Wace ✦ | 993.59K | -16.4% | $18.23M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 13 | T. Rowe Price ✦ | 621.01K | -5.9% | $11.40M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 14 | T. Rowe Price ✦ | 621.01K | -5.9% | $11.40M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 15 | Citadel Advisors ✦ | 337.87K | +101.6% | $6.20M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 16 | Citadel Advisors ✦ | 337.87K | +101.6% | $6.20M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 17 | Fisher Asset Management ✦ | 327.50K | +68.3% | $6.01M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 18 | Gotham Asset Management ✦ | 69.97K | +95.8% | $1.28M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 65.18K | +76.5% | $1.20M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 65.18K | +76.5% | $1.20M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 65.18K | +76.5% | $1.20M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 22 | Wellington Management ✦ | 55.71K | -11.0% | $1.02M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 23 | Wellington Management ✦ | 55.71K | -11.0% | $1.02M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 24 | Wellington Management ✦ | 55.71K | -11.0% | $1.02M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 25 | Wellington Management ✦ | 55.71K | -11.0% | $1.02M | 0.0% | ▼ Trim | 3 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Point72 Asset Management | $40.94M | 0.1% |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 337 持有人, 164.47M 股份, $3.62B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q4 2024 ·
方法论 ·
通过API获取此数据